Browse by Poster Author

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Poster Author

Type here to filter the list

E
Eastwood, Sophie

University College London
(159) Insomnia Symptom Prevalence in England: A Comparison of Self-Reported Data and Primary Care Records in the UK Biobank
Sophie Eastwood
Favorite
Eberl, Sonja

Department of Paediatrics and Adolescents Medicine, Universitätsklinikum Erlangen
(235) Drug utilization in children at a German university hospital – Are evidence-based (off-label) dosing recommendations available?
Sonja Eberl
Favorite
(246) Quality assessment of medication data from routine paediatric inpatient documentation – A prerequisite for drug utilisation studies
Sonja Eberl
Favorite
Eberst, Kyle

egnite, Inc.
(151) Case Study With a Cardiovascular Outcomes Trial for a Glucagon-Like Peptide-1 Receptor Agonist: Evaluating Trial Generalizability With an Enriched Electronic Health Record-Based Database
Kyle Eberst
Favorite
Ebert, Natalie

Institut für Public Health, Charité - Universitätsmedizin Berlin
(196) Use of SGLT2 Inhibitors in Patients With Type 2 Diabetes and Chronic Kidney Disease – a Multi-Country Report from the FOUNTAIN Platform
Natalie Ebert
Favorite
Echevarria Gonzalez, Luis

Department of Health of the Basque Government, Vitoria-Gasteiz, Spain
(310) Risk of congenital ocular anomaly in EUROmediCAT: Assessment of the Potential Risk of Taking Medications during Pregnancy in Europe.
Luis Echevarria Gonzalez
Favorite
Eckrote, Michael

HealthVerity
(161) Linking clinical trial participants to their U.S. real-world data through tokenization: a practical guide
Michael Eckrote
Favorite
Edfors, Robert

Bayer AG
(129) Short- and Long-Term Associations of Hyperkalemia-related Events on Serum Potassium Time Courses in Patients with Chronic Kidney Disease: A Retrospective Cohort Study Using Electronic Health Records Data from the United States
Robert Edfors
Favorite
(183) Feasibility of Constructing an External Control Arm with Real-World Data to Augment Subgroups in Cardiorenal Trials: A Matched Cohort Study Focusing on Trial Subgroups of Sodium-Glucose Cotransport 2 Inhibitor Users at Baseline
Robert Edfors
Favorite
Edmonds, Chris

AstraZeneca, Gaithersburg, USA
(024) Mortality in an Eosinophilic Granulomatosis with Polyangiitis (EGPA) Incident Cohort: A Retrospective Study in England
Chris Edmonds
Favorite
Edrees, Heba

Brigham and Women's Hospital
(205) Co-Administration of Oxycodone and CYP3A4-Inhibiting Calcium Channel Blockers and Opioid Overdose: Real-World Evidence from Population-based Claims Data in the United States, 2000-2020.
Heba Edrees
Favorite
Edward Lewis, Leslie

Department of Paediatrics, Kasturba Medical College,Manipal Academy Of Higher Education
(233) Development of a multivariate prognostic model to predict mortality in neonatal sepsis patients.
Leslie Edward Lewis
Favorite
Edwards, Jodi

University of Ottawa, Ottawa, Ontario, Canada
(165) Effectiveness of early versus delayed post-discharge sodium-glucose cotransporter-2 inhibitor initiation in acute heart failure with type 2 diabetes: a population-based cohort study
Jodi Edwards
Favorite
Edwards, Susan

F. Hoffmann-La Roche Ltd
(300) Assessing the feasibility of TREAT-NMD registries for characterising adult patients with SMA receiving risdiplam treatment
Susan Edwards
Favorite
Effler, Paul

5. Communicable Disease Control Directorate, Western Australia Department of Health, Perth, Australia
(354) Real-world Nuvaxovid COVID-19 vaccine safety profile after first 100,000 doses in Australia
Paul Effler
Favorite
Eggebrecht, Lisa

ZEG – Berlin Center for Epidemiology and Health Research
(162) Switching and continuation patterns of consecutive IUD users - results from a large observational, real-world study in Europe (EURAS-LCS12)
Lisa Eggebrecht
Favorite
(BSPOT13) Does an additional gold or silver alloy provide any benefit over copper-only intrauterine devices? Insights from the EURAS-LCS12 study
Lisa Eggebrecht
Favorite
Eggemann, Katharina

Leibniz Institute for Prevention Research and Epidemiology - BIPS
(010) Cardiotoxic Cancer Treatment in Screen-Detected Versus Non-Screen-Detected Breast Cancer Patients: A Study Based on German Claims Data
Katharina Eggemann
Favorite
Eggenschwiler, Laura

Vista Augenklinik, Binningen, Switzerland
(327) Characteristics of a population using anti-glaucoma therapy in the UK CPRD GOLD
Laura Eggenschwiler
Favorite
Egger, Pascal

Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacy and Epidemiology, Department of Pharmaceutical Sciences, University of Basel
(051) Dipeptidyl Peptidase-4 Inhibitors and Inflammatory Bowel Disease Risk: Impact of Study Design Differences on Treatment Effect
Pascal Egger
Favorite
Egloff, Shanna

HCA Healthcare
(105) Hospital-level Variation in COVID-19 Treatment Among Hospitalized Adults in the United States: A Retrospective Cohort Study
Shanna Egloff
Favorite
Ehrenstein, Vera

Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital
(201) Drug Utilisation Study of Radium-223 Under Routine Clinical Practice (DIRECT) in Europe: A Post-authorisation Safety Study
Vera Ehrenstein
Favorite
(214) Characteristics and drug utilization patterns of patients with migraine initiating erenumab in Nordic countries
Vera Ehrenstein
Favorite
(273) Gabapentin in Pregnancy and Birth Outcomes: a Population-based Prevalence Study in Nordic Countries (EUPAS38620)
Vera Ehrenstein
Favorite
(367) VAC4EU study to identify risk factors and characterize the clinical course of myocarditis/pericarditis following mRNA-1273 vaccination in four European countries: first descriptive analyses
Vera Ehrenstein
Favorite
Ehresmann, Kirsten

Pregnancy and Child Health Research Center, HealthPartners Institute
(123) Racial and language disparities in initial COVID-19 vaccination during lactation
Kirsten Ehresmann
Favorite
(153) Evaluating the Accuracy of Infant Weight and Length Measurements from Electronic Health Records for Use in Maternal Vaccination Safety Studies
Kirsten Ehresmann
Favorite
(262) Antidepressant and Psychotherapy Initiation Among Patients with New Episodes of Depression During Pregnancy
Kirsten Ehresmann
Favorite
(274) Language and racial disparities in initial COVID-19 vaccination during pregnancy
Kirsten Ehresmann
Favorite
(299) Pregnant persons' perceptions of RSV vaccination during pregnancy
Kirsten Ehresmann
Favorite
(355) Tetanus, Diphtheria, Pertussis (Tdap) Vaccination During Pregnancy and Initiation of Human Milk Feeding
Kirsten Ehresmann
Favorite
Ehret, Megan

University of Maryland, Baltimore
(207) Disenrollment Among Commercially-Insured Individuals in the United States with Opioid Use Disorder, 2010-2019
Megan Ehret
Favorite
(208) Early Opioid Use Disorder Treatment Pathways and Determinants Among the Commercially-Insured, 2010-2019
Megan Ehret
Favorite
EHRHARDT, Carole

Sanofi
(021) How to improve Patient centricity in Benefit-Risk Assessments (BRA)?
Carole EHRHARDT
Favorite
Ehsan, Sarah

Department of Biostatistics, Epidemiology, and Informatics (DBEI) University of Pennsylvania Perelman School of Medicine
(076) Real-World utilization of 1L systemic therapy amongst Black and Non-Hispanic White patients with advanced or recurrent endometrial cancer
Sarah Ehsan
Favorite
Eid, Muhammad

German Center for Neurodegenrative Diseases
(211) Prevalence of Medication-Related Risk Factors for Adverse Drug Reactions
Muhammad Eid
Favorite
Eijsink, Job

Department of clinical pharmacy, Isala klinieken, Zwolle, The Netherlands
(BSPOT43) Real-world overall survival after alternative dosing for pembrolizumab in the treatment of non-small cell lung cancer: a nationwide retrospective cohort study with a non-inferiority primary objective.
Job Eijsink
Favorite
E, Jian-Yu

Epidemiology & Benefit–Risk Evaluation, Sanofi
(CSPOT25) Discrete Choice Experiment (DCE) as A Tool to Elicit Patient Preferences in A Complex Benefit-Risk Evaluation: A Rimonabant Case Study
Jian-Yu E
Favorite
Ejlertsen, Bent

Department of Oncology, Rigshospitalet, Copenhagen University, Copenhagen, Denmark
(021) Ischemic Cardiotoxicity of Aromatase Inhibitors in Postmenopausal Women with Early Breast Cancer: an Analysis of Real-World Data
Bent Ejlertsen
Favorite
Ejlli, Lucian

Friuli-Venezia Giulia Regional Center of Pharmacovigilance, Trieste, Italy
(120) How much frequently are biological drugs used in patients over 65 years with immune-mediated inflammatory diseases through the Italian VALORE distributed database network
Lucian Ejlli
Favorite
(CSPOT24) Trajectories of adherence to biological drugs in patients with inflammatory bowel diseases: the VALORE project
Lucian Ejlli
Favorite
Ekanmian, Giraud

Faculty of Pharmacy, Laval University, Québec City, Canada.
(085) Adherence to Hypertension Treatment Among the Older Individuals: Do Depression and Anxiety Influence Adherence Trajectories?
Giraud Ekanmian
Favorite
Ekström, Anne-Berit

Queen Silvia Children's Hospital, Sahlgrenska University Hospital, University of Gothenburg
(317) Use of European rare disease registries to describe the natural history and disease progression of Spinal Muscular Atrophy (SMA) over time
Anne-Berit Ekström
Favorite
Ekwaru, Paul

Medlior Health Outcomes Research Ltd.
(ASPOT07) Exploring sources of statistical heterogeneity in a multi-database observational study: results from a case study using EXACOS-CV
Paul Ekwaru
Favorite
Eldemir, Lev

Datavant
(169) Quantification of information gained by linking claims data to an EHR cohort of US metastatic breast cancer (mBC) patients
Lev Eldemir
Favorite
Eldering-Heldens, Anne

Department of Pharmacy, Noordwest Ziekenhuisgroep, Alkmaar, the Netherlands
(BSPOT43) Real-world overall survival after alternative dosing for pembrolizumab in the treatment of non-small cell lung cancer: a nationwide retrospective cohort study with a non-inferiority primary objective.
Anne Eldering-Heldens
Favorite
Elders, Petra

Department of General Practice, Amsterdam UMC
(058) Migration Background and HbA1c Checks and Balances: A Large Routine Care Data Study in the Netherlands
Petra Elders
Favorite
(351) Rates of SARS-CoV-2 Breakthrough Infection or Severe COVID-19 and Associated Risk Factors After Primary and Booster Vaccination Against COVID-19 in the Netherlands
Petra Elders
Favorite
Eleftheriou, Georgios

Poison Control Center, Hospital ASST Papa Giovanni XXIII, Bergamo, Italy
(308) Reproductive safety of glucagon-like peptide 1 receptor agonists (GLP1-RA) after maternal exposure in early pregnancy: a comparative ENTIS cohort study
Georgios Eleftheriou
Favorite
Elemuwa, Uchenna

National Pharmacovigilance Centre NAFDAC Abuja Nigeria
(366) Trends of COVID-19 Vaccine Adverse Event Following Immunization (AEFI): A One-year Retrospective Review Using the Passive Surveillance Data in the Nigerian National Database (Vigiflow).
Uchenna Elemuwa
Favorite
Elferink, Andre

Dutch Medicines Evaluation Board, Utrecht, The Netherlands
(190) Do efficacy results obtained from randomised controlled trials translate to effectiveness data from observational studies for relapsing-remitting multiple sclerosis?
Andre Elferink
Favorite
El-Haddad, Chantal

Sanofi
(021) How to improve Patient centricity in Benefit-Risk Assessments (BRA)?
Chantal El-Haddad
Favorite
(042) What are the main experiences and treatment preferences of people living with achondroplasia and their caregivers?
Chantal El-Haddad
Favorite
Elhussein, Leena

University of Oxford
(029) Prevalence of dermatomyositis and polymyositis in adults and paediatric populations: a network cohort study part of DARWIN EU®
Leena Elhussein
Favorite
(124) Incidence and Complications of Rectopexy in the United Kingdom and United States, 2013-2022.
Leena Elhussein
Favorite
(297) Use of systemic fluoroquinolones in primary care and hospital settings in the UK: A population-level cohort study
Leena Elhussein
Favorite
(BSPOT33) Natural history of dermatomyositis and polymyositis in adults and paediatric populations: a network cohort study part of DARWIN EU®
Leena Elhussein
Favorite
Eliasson, Björn

Sahlgrenska University Hospital
(088) Association of Glucagon-Like Peptide-1 Receptor Agonists with Parkinson’s Disease: Scandinavian Cohort Study
Björn Eliasson
Favorite
Eliazar, Austin

HealthVerity
(161) Linking clinical trial participants to their U.S. real-world data through tokenization: a practical guide
Austin Eliazar
Favorite
Elizabeth, Sharon

JSS College of Pharmacy, Mysuru
(256) Evaluation of Antimicrobial Stewardship Metrics in General Surgery Wards
Sharon Elizabeth
Favorite
Elkrog, Sophie

University of Southern Denmark
(298) A nationwide study of psychotherapy treatment at Danish psychiatric clinics
Sophie Elkrog
Favorite
Ellenbogen, Michael

Johns Hopkins University School of Medicine
(ASPOT47) Utilization of Benzodiazepines in the U.S.: An Analysis of Medical Expenditure Panel Survey
Michael Ellenbogen
Favorite
Ellenius, Johan

Uppsala Monitoring Centre
(251) Comprehensive evaluation of algorithm demonstrates robust performance identifying pregnancy cases in VigiBase
Johan Ellenius
Favorite
Elliot, Stephanie

Medicines and Healthcare products Regulatory Agency
(124) Incidence and Complications of Rectopexy in the United Kingdom and United States, 2013-2022.
Stephanie Elliot
Favorite
(199) Proof-of-concept for a UK federated data network using the OMOP common data model: the UK regulatory studyathon
Stephanie Elliot
Favorite
(297) Use of systemic fluoroquinolones in primary care and hospital settings in the UK: A population-level cohort study
Stephanie Elliot
Favorite
Ellis, Alan

North Carolina State University
(035) Assessing the utility of claims for haemoglobin A1c performance measures in characterizing glycemic control in older adult Medicare beneficiaries with diabetes.
Alan Ellis
Favorite
(143) The prevalent new-user study design: a novel application to estimating the average treatment effect of statin discontinuation on mortality among traditional Medicare beneficiaries who discontinued statins
Alan Ellis
Favorite
(BSPOT05) Interpreting Effect Estimates Across Racial and Ethnic Categories in Propensity Score-Based Analyses: An Application in US Medicare Beneficiaries Initiating Antidiabetic Medications
Alan Ellis
Favorite
Ellison, Jacqueline

University of Pittsburgh School of Public Health
(234) Antiretroviral Initiation and Adherence between Transgender and Cisgender Medicaid Beneficiaries with HIV
Jacqueline Ellison
Favorite
Elmståhl, Sölve

Division of Geriatric Medicine, Department of Clinical Sciences in Malmö, Lund University
(092) Association of Systemic Anticholinergic Medication use and Accelerated Decrease in Lung function in Older adults.
Sölve Elmståhl
Favorite
El-Sayed Hervig, Mona

Danish Medicines Agency
(332) Associations Between the Latest Received Dose of mRNA COVID-19 Vaccine Product and Chronic or Other Types of Urticaria: Nationwide Registry-Based Cohort Study in Denmark
Mona El-Sayed Hervig
Favorite
El-Sayed, Yasser

Stanford University
(BSPOT20) Prevalence and treatment of chronic hypertension during pregnancy in a U.S. cohort, 2008-2021
Yasser El-Sayed
Favorite
Eltayeb, Ahreej

Moderna, Inc.
(125) Reproducibility of computable phenotypes for post-acute sequelae of COVID-19 (PASC) in US administrative claims data
Ahreej Eltayeb
Favorite
Eltonsy, Sherif

University of Manitoba
(263) Antiseizure medication use during pregnancy and the Risk of adverse neonatal birth outcomes in two Canadian provinces
Sherif Eltonsy
Favorite
(274) Gabapentin Use During Pregnancy and the Risk of Adverse Neonatal Birth Outcomes in two Canadian provinces
Sherif Eltonsy
Favorite
(301) Prenatal Exposure to Gabapentin and the Risk of Autism Spectrum Disorder in Children
Sherif Eltonsy
Favorite
(ASPOT42) Antiseizure Medications Use And the Risk Of Parkinson’s Disease: A 15-year Population-based Study
Sherif Eltonsy
Favorite
Emeanuru, Kelechi

PPD, part of Thermo Fisher Scientific
(056) Examination of treatment patterns amongst drug classes in metastatic non-small cell lung cancer patients across EU4, UK, and US
Kelechi Emeanuru
Favorite
Emilebacker, Magalie

Moderna, Inc.
(128) Safety of Moderna mRNA-1273.214 and mRNA-1273.222 COVID-19 bivalent vaccines: results from post-marketing surveillance in South Korea
Magalie Emilebacker
Favorite
(337) Defining a Post-vaccine Myocarditis Cohort by Applying CDC Case Definition to Structured EHR and Claims Data as a Proxy for Case Adjudication
Magalie Emilebacker
Favorite
(367) VAC4EU study to identify risk factors and characterize the clinical course of myocarditis/pericarditis following mRNA-1273 vaccination in four European countries: first descriptive analyses
Magalie Emilebacker
Favorite
Emmertsen, Katrine J

Department of Surgery, Randers Regional Hospital, Randers
(058) Surgery for Chronic Diverticular Disease - Incidence and Predictors
Katrine J Emmertsen
Favorite
Engeland, Anders

Department of Chronic Diseases, Norwegian Institute of Public Health, Bergen, Norway
(325) Utilization of Psychotropic Medications Among Patients Diagnosed with Glioma: A Multinational Drug Utilisation Study
Anders Engeland
Favorite
English, Lorna

School of Public Health, University College Cork, Cork, Ireland
(193) Temporal Trends In The Dispensing Of Anti-Hypertensive Medications In Ireland And The United Kingdom From 2017-2023
Lorna English
Favorite
Engström, Arvid

Clinical Epidemiology Division
(088) Association of Glucagon-Like Peptide-1 Receptor Agonists with Parkinson’s Disease: Scandinavian Cohort Study
Arvid Engström
Favorite
Enshaeifar, Shirin

IQVIA
(085) An Assessment of Use and Comparative Safety of GLP-1 Receptor Agonists in the Real-world Setting, 2017-2023
Shirin Enshaeifar
Favorite
(213) An Assessment of Use and Emerging Safety of Esketamine Nasal Spray in the U.S., 2019-2023
Shirin Enshaeifar
Favorite
Entrop, Joshua Philipp

Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden
(BSPOT24) Data Mining for Adverse Events of Montelukast in Children and Adolescents: A Tree-Based Scan Statistics Analysis of Swedish Nationwide Data
Joshua Philipp Entrop
Favorite
Ephross, Sara

Syneos Health
(270) Impacts of Dobbs Decision and COVID-19 on Abortion-related Trends within TriNetX Electronic Medical Record Data
Sara Ephross
Favorite
(281) Progress Towards Enrollment in a US Pregnancy Registry for Galcanezumab and Lasmiditan
Sara Ephross
Favorite
(359) Vaccination Use among Pregnant Women 2016-2023: An Analysis Using Healthcare Claims
Sara Ephross
Favorite
Eriator, Ike

University of Mississippi Medical Center
(076) Incidence of opioid dose tapering among older adults enrolled in Medicare
Ike Eriator
Favorite
Erichsen, Rune

Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital
(040) Trends in Management of Inflammatory Bowel Disease in Sweden and Norway, 1982-2016
Rune Erichsen
Favorite
(058) Surgery for Chronic Diverticular Disease - Incidence and Predictors
Rune Erichsen
Favorite
(CSPOT38) Do Multimorbidity, Polypharmacy, and Socioeconomic Position Interact to Increase Colorectal Cancer Mortality? A Danish Nationwide, Population-Based Cohort Study
Rune Erichsen
Favorite
Eriksson, Julia

Department of Medicine Solna, Centre for Pharmacoepidemiology, Karolinska Institutet, Stockholm, Sweden
(160) Intention to treat and on treatment exposure definition in observational safety studies: a simulation study using real world data
Julia Eriksson
Favorite
(CSPOT21) The Risk of Venous Thromboembolism in Two of the Most Common Inflammatory Skin Diseases - a Comparative Cohort Study Consisting of the Adult Populations of Atopic Dermatitis and Psoriasis in the Swedish Specialist Care
Julia Eriksson
Favorite
Ernst, Martin

University of Southern Denmark
(298) A nationwide study of psychotherapy treatment at Danish psychiatric clinics
Martin Ernst
Favorite
Eron, Joseph

University of North Carolina at Chapel Hill
(CSPOT02) Gender Differences in Statin Persistence across Racial and Ethnic Groups among Persons with HIV in the United States
Joseph Eron
Favorite
Escolano, Sylvie

Inserm
(252) Covid19 Vaccination During Pregnancy: a Descriptive Study of Uptake and Safety for Mothers and Infants Using the Nationwide French National Health System
Sylvie Escolano
Favorite
Eskildsen, Lene Friis

5Department of Obstetrics and Gynecology, Copenhagen University Hospital-Amager and Hvidovre, Copenhagen, Denmark
(181) Validation of obstetric diagnosis and procedure codes in the Danish National Patient Registry
Lene Friis Eskildsen
Favorite
Espallargues, Mireia

Agency of Health Quality and Assessment of Catalonia
(068) Contemporary Management of Patients After Hip Fracture. A Population-Based Cohort of Over 120.000 Patients in Spain.
Mireia Espallargues
Favorite
Espinosa Daudí, Andrea

German Institute for Drug Use Evaluation (DAPI), Berlin, Germany
(ASPOT23) Trends in Use of Antipsychotics in Germany 2014–2023: A Nationwide Population-based Study
Andrea Espinosa Daudí
Favorite
Espinoza, Sandra

University of Chile
(323) Trends In Psychotropic Medication Utilisation in Community Pharmacies In Chile Between 2018 - 2022
Sandra Espinoza
Favorite
Esposito, Daina

Moderna, Inc.
(102) Evaluation of postmenopausal hemorrhage following Moderna COVID-19 vaccines: results from surveillance data analysis and interim results from a US claims database cohort study
Daina Esposito
Favorite
(125) Reproducibility of computable phenotypes for post-acute sequelae of COVID-19 (PASC) in US administrative claims data
Daina Esposito
Favorite
(128) Safety of Moderna mRNA-1273.214 and mRNA-1273.222 COVID-19 bivalent vaccines: results from post-marketing surveillance in South Korea
Daina Esposito
Favorite
(129) Safety of Moderna’s mRNA-1273.222 bivalent omicron-containing vaccine: interim results from a US claims database cohort study
Daina Esposito
Favorite
(279) Post-Marketing Safety Surveillance of Vaccines in Japan for Older Adults: A Feasibility Assessment of Real-World Data Capabilities
Daina Esposito
Favorite
(330) A Comparison of Natural Language Processing (NLP) vs Clinician Review for Identification of Myocarditis Cases Following Vaccination with mRNA-1273
Daina Esposito
Favorite
(337) Defining a Post-vaccine Myocarditis Cohort by Applying CDC Case Definition to Structured EHR and Claims Data as a Proxy for Case Adjudication
Daina Esposito
Favorite
(341) Early use of Moderna’s mRNA-1273.815 monovalent vaccine: a descriptive analysis of a US Claims database
Daina Esposito
Favorite
(367) VAC4EU study to identify risk factors and characterize the clinical course of myocarditis/pericarditis following mRNA-1273 vaccination in four European countries: first descriptive analyses
Daina Esposito
Favorite
Essink, Sharon

Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.
(CSPOT43) Risk Management of Authorised Advanced Therapy Medicinal Products in the EU
Sharon Essink
Favorite
Esslinger, Suzan

Cilag GmbH International
(CSPOT17) A post-authorization safety study of golimumab in ulcerative colitis using the Spanish ENEIDA registry (MK8259-042)
Suzan Esslinger
Favorite
Esteban-Cledera, Laura

Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)
(363) The Association between COVID-19 Vaccines and Menstrual Disorders: A Systematic Review.
Laura Esteban-Cledera
Favorite
Etain, Bruno

INSERM U1144, Faculté de Pharmacie de Paris, Université Paris Cité, Paris, France.
(320) Therapeutic strategies after discontinuation of valproate in clinical practice in women with bipolar disorder: a cohort study in the United Kingdom and France databases
Bruno Etain
Favorite
Etminan, Mahyar

Department of Ophthalmology and Visual Sciences, Faculty of Medicine,The University of British Columbia, Vancouver, BC, Canada
(050) Association Between Aromatase Inhibitors and Dry Eye Disease Among Women with Breast Cancer
Mahyar Etminan
Favorite
Etter, Katherine

Johnson & Johnson
(156) How well does hospital billing data estimate readmissions and revision risks after spinal fusion surgery compared to hospital billing linked to claims data?
Katherine Etter
Favorite
Etuk, Victoria

Nigerian Institute of Human Virology
(366) Trends of COVID-19 Vaccine Adverse Event Following Immunization (AEFI): A One-year Retrospective Review Using the Passive Surveillance Data in the Nigerian National Database (Vigiflow).
Victoria Etuk
Favorite
Eurich, Dean

University of Alberta
(152) Evaluating Methods to Define Place of Residence in Administrative Data and the Impact on Observed Associations
Dean Eurich
Favorite
Evans, Alison

Drug Safety Research Unit
(333) Case Series Analysis of Immune-Mediated Neurological Events in Vaccinees following AZD1222 (ChAdOx1 nCoV-19): Results from a UK Post-authorisation Active Surveillance Study
Alison Evans
Favorite
(338) Cumulative Rates of Serious and Adverse Events of Special Interest in Vaccinees Following AZD1222 (ChAdOx1 nCoV-19): Results from a UK Post-authorisation Active Surveillance Study
Alison Evans
Favorite
(349) Observed versus Expected Analysis of Adverse Events of Special Interest after AZD1222 (ChAdOx1 nCoV-19) Vaccination: Results from a UK Post-authorisation Active Surveillance Study
Alison Evans
Favorite
Evans, Stephen

London School of Hygiene and Tropical Medicine
(BSPOT51) Signal Monitoring for Adverse Events Following Immunization with COVID-19 Vaccines During the SARS-CoV-2 Pandemic: An Evaluation of the South African Surveillance System
Stephen Evans
Favorite
Ewig, Celeste LY

University of Florida
(141) Assessing Exposure to Recently Approved Medications to Inform Feasibility for Signal Identification Analyses in the FDA’s Sentinel System
Celeste LY Ewig
Favorite
(199) Analysis of New Molecular Entity Utilization Patterns using the Sentinel Distributed Database
Celeste LY Ewig
Favorite
(248) Surveillance of outcomes identified with use of biologics indicated for asthma: a comparison of events observed with pediatric utilization
Celeste LY Ewig
Favorite
(265) Finding the Forest in the TreeScan: A Big Data Driven Approach to Screening Drug Use in Pregnancy
Celeste LY Ewig
Favorite
(291) Postpartum Treatment Initiation among Pregnancies Diagnosed with Hepatitis C between 2016-2021 using the United States Commercial Claims Data
Celeste LY Ewig
Favorite
(BSPOT30) Pediatric Utilization of New Molecular Entities (NMEs): A Summary of Early Post-marketing Uptake in the Sentinel Distributed Database
Celeste LY Ewig
Favorite
Ewing, Alexander

Centers for Disease Control and Prevention
(302) Prenatal syphilis in the US: characterizing screening and treatment during pregnancy in publicly and commercially insured individuals
Alexander Ewing
Favorite
Eworuke, Efe

IQVIA
(228) Beta-blocker-associated Hypoglycemia in Pediatric Patients: Findings from the FDA Adverse Event Reporting System, National Poison Data System, Medical Literature, and Sentinel Distributed Database
Efe Eworuke
Favorite
(250) Comparison of Diagnoses Code Profile and Major Congenital Malformation (MCM) Prevalence across US and EU MCM Classification Systems
Efe Eworuke
Favorite
Exalto, Lieza

Julius Clinical
(190) Investigation of inclusion and exclusion criteria in Alzheimer’s disease clinical trials on patient sample representation through natural language processing
Lieza Exalto
Favorite
Exton, Lesley

Willan House, British Association of Dermatologists, London, UK
(036) Serious Infection Risk Associated With Biologics and Systemic Nonbiologics in Patients With Psoriasis: A Systematic Review and Network Meta-Analysis of Randomised Controlled Trials
Lesley Exton
Favorite
Ezejimofor, Martinsixtus

Willan House, British Association of Dermatologists, London, UK
(036) Serious Infection Risk Associated With Biologics and Systemic Nonbiologics in Patients With Psoriasis: A Systematic Review and Network Meta-Analysis of Randomised Controlled Trials
Martinsixtus Ezejimofor
Favorite
Ezenduka, Charles

University of Nigeria Enugu Campus
(073) The Health Status & Related Quality of Life among Patients with T2DM using EQ-5D-5L Instrument at a Tertiary Healthcare Facility in Nigeria.
Charles Ezenduka
Favorite
Ezzy, Stephen

Optum
(237) Infant Growth and Development Outcomes among Commercially Insured Infants in the United States, 2016 – 2023
Stephen Ezzy
Favorite
(347) Interim Utilization Results from a Post-Approval Safety Study of Pfizer-BioNTech Monovalent COVID-19 Vaccine in the United States
Stephen Ezzy
Favorite